Biogen Inc. buy Royal Bank of Canada
Start price
02.08.24
/
50%
€188.45
Target price
02.08.25
€267.50
Performance (%)
-39.72%
End price
03.08.25
€113.60
Summary
This prediction ended on 03.08.25 with a price of €113.60. The BUY prediction by Royal_Bank_of_Canada for Biogen Inc. performed very badly with a performance of -39.72%. Royal_Bank_of_Canada has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 0.639% | 0.639% | -26.179% |
| iShares Core DAX® | 0.299% | 2.868% | 24.199% |
| iShares Nasdaq 100 | 2.257% | 3.363% | 15.433% |
| iShares Nikkei 225® | 5.054% | 8.119% | 17.673% |
| iShares S&P 500 | 1.414% | 2.409% | 8.343% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Royal Bank of Canada from $282.00 to $292.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten